Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
1.010
-0.010 (-0.98%)
At close: May 12, 2025, 4:00 PM
1.040
+0.030 (2.97%)
After-hours: May 12, 2025, 6:42 PM EDT
Iterum Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Iterum Therapeutics stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 9.00. The average target predicts an increase of 593.07% from the current stock price of 1.01.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Iterum Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +791.09% | May 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +395.05% | Sep 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +395.05% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +494.06% | Jun 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +494.06% | May 31, 2024 |
Financial Forecast
Revenue This Year
9.52M
Revenue Next Year
19.84M
from 9.52M
Increased by 108.39%
EPS This Year
-0.65
from -1.26
EPS Next Year
-0.52
from -0.65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.8M | 20.4M | 43.1M | ||
| Avg | 9.5M | 19.8M | 41.9M | ||
| Low | 9.1M | 19.1M | 40.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 114.5% | 117.3% | ||
| Avg | - | 108.4% | 111.1% | ||
| Low | - | 100.2% | 102.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.67 | -0.54 | 0.07 |
| Avg | -0.65 | -0.52 | 0.07 |
| Low | -0.63 | -0.50 | 0.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.